The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

SNDX FINANCIAL STATEMENTS

Syndax Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

SNDXSyndax Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M0200 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue252 M $Gross Profit245.6 M $ · 97%Operating Income-194.2 M $ · -77%Pre-tax Income-220.8 M $ · -88%Net Income to Owners-220.8 M $ · -88%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue252 M $+222.3%
Gross Profit245.6 M $+223.1%
Operating Income-194.2 M $—
EBITDA-135.2 M $—
Net Income to Owners-220.8 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M600 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets703.7 M
  • Equity15.1 M $2%
  • Current Liabilities99.7 M $14%
  • Long-term Liabilities588.9 M $84%

Key Figures

YoY change
Total Assets703.7 M $+18.0%
Total Liabilities688.6 M $+56.9%
Total Equity15.1 M $-90.4%
Cash & ST Investments547.9 M $+16.9%
Total Debt589.4 M $+35,087.0%
Net Debt252.9 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-300 M-200 M-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-200 M0200 M-220.6 M $Operating175.5 M $Investing272.9 M $Financing227.7 M $Net Change

Key Figures

YoY change
Operating Cash Flow-220.6 M $—
Capital Expenditures227 K $—
Free Cash Flow-220.9 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on SNDX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.